Opicapone to Treat Early Wearing-off in Parkinson's Disease Patients: The Korean ADOPTION Trial.
Jee-Young LeeHyeo Il MaJoaquim José FerreiraJosé-Francisco RochaYoung Hee SungJae-Uk SongTae-Beom AhnDo Young KwonSang-Myung CheonJong Min KimChong Sik LeePhil Hyu LeeJeong-Ho ParkJae-Hyeok LeeMee Young ParkSang Jin KimJong Sam BaikSeong-Min ChoiHae-Won ShinHo-Won LeeSuk-Yun KangBeom Seok JeonPublished in: Movement disorders clinical practice (2024)
Opicapone 50 mg was more effective than an additional 100 mg L-dopa dose at decreasing off time in patients with PD and early wearing-off.